Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors

Molecular Pharmacology

Volumn 58, Issue 1, 2000, Pages 82-88

  Jiang, Lin Hua ^a   Mackenzie, Amanda B ^a   North, R Alan ^a   Surprenant, Annmarie ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRILLIANT BLUE; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG UPTAKE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0033932598     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.1.82     Document Type: Article

References (46)

1. Buell G, Lewis C, Collo G, North RA and Surprenant A (1996) Antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J 15:55-62.
2. Burnstock G (1999) Current status of purinergic signalling in the nervous system. Prog Brain Res 120:3-10.
3. 7 receptor-activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 83:196-203.
4. Chessell IP, Michel AD and Humphrey PP (1997) Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol 121:1429-1437.
5. 7 receptor. Br J Pharmacol 124:1314-1320.
6. Christofferson BC, Hug MJ and Novak I (1998) Different purinergic receptors lead to intracellular calcium increases in pancreatic ducts. Pflugers Arch 436:133-139.
7. 7 receptor. Neuropharmacology 36:1277-1283.
8. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16:2495-2507.
9. 7 receptor of microglial cells: A novel immunomodulatory receptor. Prog Brain Res 120:355-368.
10. Evans RJ, Lewis C, Buell G, Valera S, North RA and Surprenant A (1995) Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X-purinoceptors). Mol Pharmacol 48:178-183.
11. Evans RJ, Surprenant A and North RA (1997) P2X receptors: Cloned and native, in P2 Nucleotide Receptors (Turner JT, Weisman GA and Fedan JS eds) pp 43-61, Humana Press Inc., Totowa, New Jersey.
12. 4 receptor reveals pharmacological differences with the rat homologue. Mol Pharmacol 51:109-118.
13. Gargett CE and Wiley JS (1997) The isoquinoline derivative KN-62: A potent antagonist of the P2Z receptor of human lymphocytes. Br J Pharmacol 120:1483-1490.
14. Groschel-Stewart U, Bardini M, Robson T and Burnstock G (1999) P2X receptors in the rat duodenal villus. Cell Tissue Res 297:111-117.
15. Humphreys BD, Virginio C, Surprenant A, Rice J and Dubyak G (1998) Isoquinolines as antagonists of the P2X7 nucleotide receptor: High selectivity for the human versus rat receptor homologues. Mol Pharmacol 54:22-32.
16. Kawashima E, Estoppey D, Virginio C, Rees S, Surprenant A and North RA (1998) A novel and efficient method for the stable expression of heteromeric ion channels in mammalian cells. Receptors Channels 5:53-60.
17. Kenakin TP (1993) Pharmacological Analysis of Drug-Receptor Interaction, 2nd ed., Raven Press, New York.
18. 4 receptor-channels. J Neurosci 19:7289-7299.
19. 1 receptors. Br J Pharmacol 128:981-988.
20. 2 receptor. Br J Pharmacol 121:1445-1453.
21. 6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci 18:7152-7159.
22. 5 subunits. J Biol Chem 274:15415-15419.
23. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature (Lond) 377:432-435.
24. Li C, Peoples RW and Weight FF (1996) Proton potentiation of ATP-gated ion channel responses to ATP and Zn2+ in rat nodose ganglion neurons. J Neurophysiol 76:3048-3058.
25. Li C, Peoples RW and Weight FF (1997) Mg2+ inhibition of ATP-activated current in rat nodose ganglion neurons: Evidence that Mg2+ decreases the agonist affinity of the receptor. J Neurophysiol 77:3391-3395.
26. Mackenzie A, Surprenant A and North RA (1999) Functional and molecular diversity of purinergic ion channel receptors. Ann NY Acad Sci 868:716-729.
27. Markwardt F, Klapperstuck M, Lohn M, Riemann D, Buttner C and Schmalzing G (1999) Purinoceptors in human B-lymphocytes. Prog Brain Res 120:345-353.
28. McMillian MK, Soltoff SP, Cantley LC, Rudel R and Talamo BR (1993) Two distinct cytosolic calcium responses to extracellular ATP in rat parotid acinar cells. Br J Pharmacol 108:453-561.
29. 1 receptors. Nature (Lond) 403:86-89.
30. North RA and Barnard EA (1997) Nucleotide receptors. Curr Opin Neurobiol 7:346-357.
31. North RA and Surprenant A (2000) Pharmacology of P2X receptors. Annu Rev Pharmacol Toxicol 40:563-580.
32. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
33. 7: Cloning and expression of a human cDNA. J Biol Chem 272:5482-5486.
34. Seguela P, Haghighi A, Soghomonian JJ and Cooper E (1996) A novel neuronal P2X ATP receptor ion channel with widespread distribution in the brain. J Neurosci 16:448-455.
35. Soltoff SP, McMillian MK and Talamo BR (1989) Coomassie Brilliant Blue G is a more potent antagonist of P2 purinergic responses than Reactive Blue 2 (Cibacron Blue 3GA) in rat parotid acinar cells. Biochem Biophys Res Commun 165:1279-1285.
36. 7). Science (Wash DC) 272:735-738.
37. 4 and P2Z receptors for extracellular ATP in parotid acinar cells. J Biol Chem 41:26799-26808.
38. 2+ responses: Role of protein kinases. Biochem J 295:255-261.
39. Thomas S, Virginio C, North RA and Surprenant A (1998) The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones. J Physiol (Lond) 509:411-417.
40. Torres GE, Egan TM and Voigt MM (1999) Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J Biol Chem 274:6653-6659.
41. 5 receptor subunits reveals a novel ATP-gated ion channel. Mol Pharmacol 54:989-993.
42. 2x purinoceptors. Naunyn Schiedebergs Arch Pharmacol 351:603-609.
43. 7 receptor. Neuropharmacology 36:1285-1294.
44. 7 receptor. J Physiol (Lond) 519:335-346.
45. 2/3 receptors. Mol Pharmacol 53:969-973.
46. 2 and P2X3 receptor subunits in monkey and rat sensory neurons and their central terminal. Neuropharmacology 38:1229-1242.